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Abstract
Zinc is essential for normal brain development. Gestational severe zinc deficiency can lead to
overt fetal brain malformations. Although not teratogenic, suboptimal zinc nutrition during
gestation can have long-term effects on the offspring's nervous system. This paper will review
current knowledge on the role of zinc in modulating neurogenesis and neuronal apoptosis, as well
as the proposed underlying mechanisms. A decrease in neuronal zinc causes cell cycle arrest,
which in part involves a deregulation of select signals (ERK1/2, p53, NF-κB). Zinc deficiency
also induces apoptotic neuronal death through the intrinsic (mitochondrial) pathway, which can be
triggered by the activation of the zinc-regulated enzyme caspase-3, and as a consequence of
abnormal regulation of pro-survival signals (ERK1/2, NF-κB). Alterations in the finely-tuned
processes of neurogenesis, neuronal migration, differentiation and apoptosis, that involve the
developmental shaping of the nervous system, could have a long-term impact on brain health. Zinc
deficiency during gestation, even at the marginal levels observed in human populations, could
increase the risk for behavioral/neurological disorders in infancy, adolescence and adulthood.
Keywords
Zinc; neuron; proliferation; apoptosis; caspase; NF-κB; ERK; zinc deficiency; p53; Bad
1. Introduction
Zinc is one of the most abundant essential elements in the human body. It is present in the
structure of many proteins, like enzymes and transcription factors and modulates the
function of other proteins, including receptors, enzymes and proteins involved in cell
signalling. Zinc is a key micronutrient in the physiology of the nervous system, participating
in the modulation of synaptic transmission [1, 2], regulation of neuronal cell oxidant
production [3, 4], regulation of signalling cascades [5-9]; neural cell proliferation [10-13],
cell survival [9-12, 14] and neuronal differentiation [15, 16]. The physiological functions of
zinc in the nervous system depend on a fine balance of intra and extracellular zinc
concentrations [2, 17]. Elevations in neuronal zinc levels that are associated with select brain
injury conditions lead to apoptotic cell death [18, 19]. On the other hand, severe gestational
zinc deficiency is characterized by fetal malformations including agenesis and
dysmorphogenesis of the brain, spinal cord, eye and olfactory tract [20, 21]. A marginal zinc
nutrition during gestation and early postnatal development is not teratogenic but affects
neurotransmission and cell signalling [5, 22]. Furthermore, early postnatal zinc deficiency
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affects the number and differentiation of basket and stellate [15], Purkinje [16], and
cerebellum granule neurons [23].
The adverse effects of zinc deficiency on brain development could constitute a risk for the
onset of neurological disorders during infancy, adolescence and adulthood [24]. In this
review we will addess current knowledge on the impact of zinc deficiency on two processes
that are central to normal brain development: neurogenesis and neuronal apoptosis. The
proposed mechanisms (summarized in Fig.1) will be discussed.
2. Zinc and neuronal apoptosis
Neuronal apoptosis occurs as a physiological and critical event in the normal development
of the nervous system. However, it also occurs as a consequence of brain injury and disease.
Extracellular and intracellular stimuli such as trophic factors, oxidative stress, neurotoxins
and DNA damage act upon neurons leading to life or apoptotic death decisions. A finely
tuned regulation of the cell cycle is essential for cell proliferation and differentiation, but it
can also participate in the triggering of neuronal death. In this regards, the re-entry of
postmitotic neurons in the cell cycle induces cell death instead of proliferation [25][26].
The mechanisms of apoptosis are specific for particular cell types and also depend on the
apoptotic signal that initiates the cascade. Zinc depletion induces apoptosis in different cells
and tissues (reviewed in [27-29]). In neuronal cells, both low and high zinc concentrations
can trigger apoptosis. The accumulation of chelatable zinc in neurons can induce neuronal
death after ischemia, epileptic seizures or brain injury by trauma [18, 19]. Cho et al. [30]
proposed that endogenous neuronal zinc can physiologically regulate apoptosis. This was
based on the finding that the subcutaneous injection of the chelator N,N,N′,N′-tetra-kis(2-
pyridylmethyl)ethylenediamine (TPEN) into 7-day-old rats decreased the number of
apoptotic neurons in the brain as compared to controls. However, these results as well as
others that use TPEN to decrease cellular zinc should be carefully interpreted. TPEN will
chelate zinc pools based on its relatively very high affinity for zinc compared to
physiological cell zinc ligands. Thus, TPEN-chelatable zinc will not necessarily reflect the
zinc pools that are physiologically involved in the regulation of neuronal function and
survival.
In neuronal cells, human neuroblastoma IMR-32 cells and primary rat cortical neurons, zinc
deficiency induced apoptotic cell death via the intrinsic pathway [10]. In this pathway [31],
mitochondrial components (cytochrome c) present in the space between the inner and outer
membranes are released to the cytosol as a consequence of mitochondrial outer membrane
permeabilization (MOMP). Members of the Bcl-2 family of proteins regulate MOMP, with
select protein components (Bcl2, Bcl-xL) that prevent MOMP; and pro-apoptotic proteins
(Bad, Bax) that act promoting MOMP. In the cytosol, cytochrome c assembles with the
proteins Apaf-1 and caspase-9 forming the apoptosome, with a consequent activation of
caspase-9. Caspase-9 activates the executioner caspase-3, which will subsequently cleave
several proteins initiating a sequence of catabolic events. In IMR-32 cells and cortical
neurons the occurrence of apoptosis via the intrinsic pathway was evidenced by an increase
of the pro-apoptotic protein Bad in the mitochondrial fraction of zinc-deficient cells, the
associated release of cytochrome c to the cytosol, caspase-3 activation, and subsequent DNA
fragmentation [10] (Fig.1).
Although the mechanisms underlying the induction of apoptosis by zinc deprivation are still
unclear, the activation of p53, of certain members of the caspase family of cystein-proteases,
and oxidative stress, have been proposed to play a role.
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3. Mechanisms of zinc-deficiency-induced neuronal apoptosis
3.a. Zinc deficiency and the tumor suppressor gene product p53
The tumor suppressor gene product p53 participates in cellular stress responses by
regulating cell cycle arrest, apoptosis, senescence, DNA repair and genetic stability [32].
Lane [33] called p53 “the guardian of the genome” because it causes cell cycle arrest in
response to DNA damage, allowing DNA repair before the progression of the cell cycle
occurs [34]. Depending on the cell type, p53 can also trigger apoptosis as a consequence of
DNA damage [35].
During apoptosis, p53 acts as a transcription factor increasing the expression levels of pro-
apoptotic proteins such as PUMA (p53-up-regulated modulator of apoptosis) and NOXA
[36]. Cytoplasmic p53 also interacts with the anti-apoptotic members Bcl-xL and Bcl-2,
leading to mitochondrial membrane permeabilization [37]. In human hepatoblastoma HepG2
cells, zinc depletion increases p53 mRNA and nuclear p53 protein levels, and zinc repletion
results in a normal abundance of the transcript [38]. Zinc plays a structural role in
maintaining p53 stability and its DNA binding capacity [39, 40]. In cultured human aortic
endothelial cells, p53 and downstream targets, as well as events resulting from p53 increase
(Bax, Bcl-2 and caspase-3 activation) are responsive to low or elevated cellular zinc levels
[41].
We studied the role of zinc in the modulation of neuronal apoptosis, by investigating the
effects of incubating human neuroblastoma IMR-32 cells and primary cultures of rat cortical
neurons in zinc-depleted media. Zinc depleted media was obtained by incubating the serum
in the presence of the chelator diethylenetriamine pentaacetic acid (DTPA), the subsequent
removal of DTPA by extensive dialysis, and final adjustment of zinc, iron, copper and
protein concentrations of the 10% (v/v) serum-containing media [42]. An increase in p53
protein levels was observed after 6 to 24 h of culturing cells in zinc deficient medium. Zinc
deficiency induced IMR-32 cell cycle arrest at the G1 phase, and apoptotic death in both
IMR-32 cells and primary cortical neurons [10] . Accordingly, Ra et al. [43] demonstrated
that p53 is essential for TPEN-induced neuronal apoptosis showing the involvement of p53-
dependent induction of PUMA/NOXA, and caspase-11-mediated activation of caspase-3.
The genetic depletion of p53 blocks the effects of TPEN on neuronal apoptosis [43]. TPEN-
induced apoptotic death in neuronal precursor cells is also associated with the expression of
the p53-dependent pro-apoptotic signal Rb-1 [11]. On the contrary, while long-term
exposure of a rat glioma cells to zinc-depleted media induces oxidative DNA damage and
p53 expression; the binding of p53 to DNA decreases, potentially affecting the expression of
p53-regulated genes [3]. Thus, p53 activation can have a central role in zinc deficiency-
triggered apoptotic neuronal death. Its role in the associated cell cycle arrest will be
subsequently discussed (
3.b. Zinc deficiency and caspase activation
While zinc depletion induces apoptosis in different cell types, zinc supplementation inhibits
internucleosomal DNA fragmentation and other characteristic morphological features of
apoptosis in vivo and in vitro [44-46]. Although there are many potential targets for the
antiapoptotic effects of zinc, the apoptotic nucleases emerge as central antiapoptotic targets.
Among these nucleases, the caspases (cysteine-aspartic acid proteases) family of proteases,
specially caspase-3, are important in determining brain cell number [47]. Caspase-3 is also
recognized to participate in other essential processes in neurodevelopment, including
neuronal differentiation and dendrite pruning (reviewed in [48]).
Caspase-3 activation involves the proteolityc cleavage of a 32kDa cytosolic precursor, with
the generation of two peptides that dimerize to generate the active enzyme. Perry et al. [49]
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demonstrated that zinc inhibits caspase-3 activation at micromolar concentrations; while
millimolar concentrations of zinc inhibit caspase-6/Mch 2α, a caspase involved in the
cleavage of lamin A and in the activation of caspase-3 [50]. Furthermore, zinc inhibits the
processing of the proenzyme into the caspase-3 active form [51]. Zinc supplementation of
neuroblastoma cells suppresses butyrate/staurosporine-induced activation of caspase-3 [52].
TPEN-induced zinc depletion in HeLa cells induces apoptosis through the activation of
caspases-3, -8 and -9 [53]. In this cellular model, zinc supplementation inhibited caspase-3
activation but not caspase-8 and -9 cleavages, suggesting that zinc protects cells from
apoptosis by maintaining caspase-3 inactive [53]. In the human breast cancer cell lines
MCF-7 and MDA-MB468, zinc depletion caused apoptosis through the activation of the
mitochondrial death pathway [54]. Supporting a role of caspase-3 in zinc deficiency-
associated apoptosis, MCF-7 cells lacking the expression of caspase-3, were less sensitive to
zinc depletion [54]
In IMR-32 cells, the increase in caspase-3 activation was significant after 24 h of incubation
in zinc deficient media, remaining high up to 48 h, when neuronal apoptosis was in an
advanced stage [10]. In IMR-32 cells and cortical neurons, caspase-3 activity was
normalized by supplementing the media with zinc, which was associated with the inhibition
of apoptotic death. On the other hand, the antioxidant lipoic acid which prevents oxidant
accumulation in zinc deficient neurons [4], did not decrease caspase-3 activation and
apoptosis in IMR-32 cells and rat cortical neurons [10]. The above findings stress the
relevance of caspase-3 activation as a key factor in the triggering of apoptosis when
neuronal zinc concentrations decrease.
3.c. Zinc deficiency and apoptosis: neuronal oxidative stress and the regulation of redox
sensitive signals
Zinc deficiency can cause oxidative stress as evidenced by its association to increased levels
of cell oxidants [3, 4, 9, 55], altered activity and concentration of antioxidant enzymes [56,
57], decreased glutathione levels [58, 59], and tissue oxidative damage, including increased
lipid, protein and DNA oxidation [3, 60, 61]. An adequate zinc status can be key to the
regulation of the oxidant/antioxidant neuronal balance. In human neuroblastoma IMR-32
cells, zinc deficiency causes an increase in cell oxidants levels, particularly of H2O2 [9], a
decrease in glutathione concentrations [4], a key antioxidant defense in neurons, and an
increased activity of CuZn superoxide dismutase, and of activity and expression of Mn
superoxide dismutase [62]. Culturing IMR-32 cells in the presence of the H2O2–
metabolizing enzyme catalase, or the antioxidant α-lipoic acid, prevented the increase in
H2O2 [4, 9]. Catalase also inhibited the associated activation of the redox-sensitive Mitogen
Activated Protein Kinases (MAPKs) p38 and JNK in zinc deficient neuronal cells [9].
However, caspase-3 activation and DNA fragmentation were not prevented by catalase [9].
Furthermore, the treatment with α-lipoic acid did not inhibit the activation of caspase-3 in
IMR-32 cells and in cortical neurons [10]. Thus, the above results suggest that oxidative
stress is not the triggering event in zinc-deficiency-induced neuronal apoptosis and that JNK
and p38 are not relevant apoptosis-triggering cascades. However, although an initial increase
in neuronal oxidants may not trigger the initial apoptotic events in zinc deficient neurons,
the permeabilization of the mitochondrial membrane would ultimately result in the
uncoupling of the respiratory chain and in an increased production of reactive oxygen
species. However, this still represent an advanced stage in the apoptotic process rather than a
triggering factor. In section 5, we will discuss the potential involvement of the redox-
sensitive transcription factor NF-κB in zinc deficiency-associated neuronal apoptosis.
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4. Zinc deficiency and cell cycle progression
Zinc is also actively involved in cell proliferation and differentiation in different tissues.
Dwarfism is a characteristic symptom of zinc deficiency and is associated to a decreased
activity of the epiphyseal growth plate [63]. The epiphyseal growth plate is responsible for
longitudinal bone growth because of proliferation and differentiation of chondrocytes [64], a
process that is stimulated by zinc [65]. In vivo, zinc deficiency causes a significant decrease
of chicken chondrocyte proliferation [66], that is not affected by local growth factors such as
FGF-2, PTHrP and IGF-1. Zinc deficiency also affects the immune system and a decreased
cell proliferation could in part explain some of these effects. In mice, zinc deficiency causes
depletion of precursor lymphoid cells in the lymphoid organs causing lymphopenia and
thymus atrophy [67]. Although the involved mechanisms are not clear, zinc deficiency
caused a decreased T cell deoxythymidine kinase gene expression and cell cycle arrest at the
G1 phase [68]. Protein kinase C could also be involved in zinc-deficiency-mediated
lymphocyte-impaired responses to mitogen stimulation [69].
Although neurogenesis is essential during normal brain development, it is also relevant in
the adult brain [11]. Adult rats fed a severely zinc-restricted diet for three weeks showed a
significant decrease in neural precursor cells in the subgranular zone and granular cell layer
of the dentate gyrus [11]. In cultured human Ntera-2 neuronal precursor cells depleted of
zinc by treatment with TPEN, a significant decrease in cell proliferation was observed with
an increase in nuclear p53 [11]. A role of p53, through the upregulation of the gene reprimo,
was proposed to be involved in Ntera-2 cell cycle arrest as a consequence of zinc depletion.
A significant reduction in proliferating cells and immature neurons in the dentate gyrus of
the hippocampus was observed in zinc-deficient mice [12]. Decreased neurogenesis was also
found in the dentate gyrus of rats fed zinc deficient diets for 6 weeks [13]. Although the
above results constitute an important starting evidence, and supports a role of zinc in
neurogenesis, it should be stressed that the conditions of zinc deficiency used are extremely
severe [11-13]. Furthermore, some studies did not include a restrict-fed group, necessary to
control for the confounding factor of the anorexia associated with severe zinc deficiency
[12, 13].
Zinc deficiency causes a decreased proliferation of human neuroblastoma IMR-32 cells,
which is due to an arrest of the cell cycle in the G1 to phase S transition [10]. Cell
proliferation is induced by the activation of cyclin-dependent kinases (cdks) by the different
cyclins, while the progression of the cell cycle is inhibited by cdks inhibitors. p21, a member
of the Cip/Kip family of cdks inhibitors, is regulated by various mechanism including
transcriptional regulation, epigenetic silencing, mRNA stability and ubiquitin-dependent and
–independent degradation [70]. p21 can also be regulated by posttranslational modifications
such as phosphorylation [71]. Transcriptional modulation of p21 involves p53-dependent
and –independent mechanisms. Two p53-binding sites exist in the promoter of p21 and one
of them is involved in the response of p53 to DNA damage [72]. LaBaer et al., [73]
demonstrated that p21 can also positively modulate cell cycle progression by stabilizing the
cyclinD1/cdk4/cdk6 complexes. Wong et al., [70], found that zinc depletion in HepG2 cells
down regulates p21 mRNA and protein expression due to a decreased p21 promoter
accessibility. In the zinc deficient HepG2 cells, the arrest at the G1/S phase of the cell cycle
seems unrelated to a decrease in p21 protein levels. On the contrary, in zinc-deficient
IMR-32 neuroblastoma cells the inhibition of the G1 to phase S transition occurs
concomitantly with the upregulation of p53 and an increase of the downstream target protein
p21 [10].
Other mechanism that could underly the decreased cell proliferation observed in a zinc
deficient state is the requirement of a functional tubulin network for the proper assembly of
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the mitotic spindle during mitosis. In support of this, in IMR-32 neuronal cells as well as in
gestation day 19 fetal brain, zinc deficiency causes an impaired assembly of microtubules [8,
74].
5. Other signaling cascades involved in zinc deficiency-induced impaired
neurogenesis and neuronal apoptosis
5.a. Transcription factor NF-κB
Initially described in the immune system, transcription factor NF-κB was subsequently
found in multiple tissues, and its role in the nervous system is a current subject of active
research. The active NF-κB is constituted of protein dimers that belong to the Rel/NF-κB
family of proteins, including c-Rel, RelB, p65 (RelA), p50/p105 and p52/p100 [5]. NF-κB
dimers are localized in the cytosol in an inactive form, given their binding to the inhibitory
IκB proteins. In the canonical pathway, activation involves the phosphorylation of two
conserved serine groups in the IκB peptide by the specific IκB kinase complex (IKK) [33],
which signals the protein for polyubiquitination and degradation by the 26S proteasome.
IκB degradation unmasks a nuclear localization signal in the NF-κB dimer which drives its
translocation through nuclear pores into the nucleus. NF-κB is involved in the development
of the nervous system, regulating neuronal proliferation, migration, differentiation, survival
and cell interactions [75-78]. The NF-κB subunits are selectively expressed in the
subventricular zone and in the rostral migratory stream during early postnatal development
and also in the adult brain. This suggests their involvement in regulating the generation and
migration of new neurons [79]. In NF-κB p-50 deficient adult mice, the rate of neural
precursor proliferation was not affected [80]. However, the p50 deficient animals showed a
significant decrease in the number of hippocampus newborn neurons, and defects in short-
term special memory performance [80]. NF-κB also participates in the regulation of
synaptic plasticity, which in turn impacts learning and memory. NF-κB regulates the
transcription of multiple genes, which includes those codifying for proteins that modulate
cell proliferation (e.g. cyclin D1, c-Myc, and IL-1), and survival (Bcl2, Bcl-xL, c-IAP1,
XIAP).
Zinc deficiency affects the NF-κB signaling cascade in neuronal cells in culture and in the
developing nervous system. In IMR-32 cells, a decreased zinc availability causes the
activation of the initial events in the pathway (IκBα phosphorylation and degradation),
which occurs as a consequence of zinc deficiency-induced increase in oxidant production
[4]. However, the active NF-κB is not efficiently translocated into the nucleus secondary to
zinc deficiency-induced alterations in the normal assembly of the microtubule network [6,
8]. Functional microtubules are required for the axonal retrograde transport and nuclear
translocation of NF-κB in neurons [6, 81]. In zinc deficient neurons, a decreased nuclear
content of the NF-κB components Rel A and p50 and of NF-κB-DNA binding is observed
[6, 8]. As a consequence, a decreased expression of NF-κB-dependent genes occurs,
including those involved in the regulation of the NF-κB pathway [6], modulators of the cell
cycle progression [10] and of cell survival [6, 10]. In this regard, zinc deficiency leads to
decreased neuronal levels of the NF-κB-regulated antiapoptotic proteins c-IAP-1, which
inhibits caspases; XIAP, which interacts with critical partners in the apoptotic/antiapoptotic
cascade (caspase-3, caspase-9, DIABLO/Smac); Bcl-xL and Bcl-2 that act in the intrinsic
apoptotic pathway, inhibiting the nuclear pore opening. Furthermore, low levels of the NF-
κB-regulated cyclins D and E, could in part contribute to the cell cycle arrest and decreased
proliferation occurring as a consequence of zinc deficiency. Although the impaired activity
of NF-κB would not be an initial triggering factor in zinc deficiency-induced neuronal
apoptosis and cell cycle arrest, it could contribute to the irreversibility of both processes.
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5.b. The serine-threonine kinase (Akt) and the extracellular-signal-regulated kinase (ERK)
Akt plays a key role in cell survival. Activated by phosphorylation, Akt acts preventing
apoptosis induced by different external stimuli and in different cell types [82]. An important
event in the intrinsic apoptotic pathway is the translocation of the proapoptotic protein Bad
from the cytosol to the mitochondrial membrane, where it initiates steps leading to MOMP.
When Bad is phosphorylated at Ser112, Ser136 or Ser155, it is retained in the cytosol
through its binding to the 14-3-3 protein. Unphosphorylated Bad forms a complex with Bcl-
xL and inhibits its anti-apoptotic function [83] [84]. Bad phosphorylation is catalyzed by
ERK [85] and protein kinase A [83] that phosphorylate Ser-112, by Akt that phosphorylates
Ser-136 [86] and protein kinase A also phophorylates Ser-155 [87]. In zinc deficient
neuronal cells we observed high levels of Akt phosphorylation [10], that could be triggered
by the associated increase in cellular oxidants [9]. In this regard, Akt activation protects
NIH3T3 against apoptosis induced by H2O2 [88]. In hepatoma cells, H2O2 increases Akt
phosphorylation promoting cell proliferation, while antioxidants induces apoptosis [89].
Although Akt is in general an antiapoptotic signal, high cellular zinc concentrations
activates Akt and induces apoptosis in immortalized embryonic hippocampal cells via the
non-conventional activation of GSK-3β and tau phosphorylation [90]
In zinc- deficient IMR-32 cells and cortical neurons we observed differential patterns of
activation of the pro-survival kinases ERK and Akt [10]. While Akt was activated, ERK was
inhibited; nevertheless, the resultant was the translocation of Bad to the mitochondria and
the triggering of apoptosis in the zinc-deficient cells. This is explained by previous findings
[91] showing that the phosphorylation of Bad at its three serine residues is required to inhibit
Bad mitochondrial translocation and the prevention of apoptosis. The above results stress an
important role of ERK inactivation in zinc deficiency-induced neuronal apoptosis.
The Raf/MEK/ERK1/2 pathway regulates the cell cycle in response to different stimuli
including nutrients, mitogens, cytokines and growth factors [92]. This pathway could be
involved in the arrest of the cell cycle at the G0/G1 phase in zinc deficient IMR-32
neuroblastoma cells [10]. A low zinc availability induced a decreased ERK phosphorylation
both in human IMR-32 cells and in cortical neurons [10]. ERK phosphorylation is also
decreased in the brain of gestation day 19 fetuses from dams fed marginal zinc diets
throughout gestation, compared to controls [5]. ERK is central to multiple pathways given
that it phosphorylates and activates several targets in the cytosol and in the nucleus. Among
these targets, several of them promote cell growth including RSK, c-Myc and ELK. In the
nervous system, ERK participates in the modulation of brain development and function [93],
being involved in the promotion of neurogenesis [94]. For example, ERK2 deletion in mice
causes decreased cortical neurogenesis and impaired neuronal differentiation [95].
Supporting the finding in zinc deficient neuroblastoma cells [96], the activation of ERK
during the cell G1 phase is necessary for the subsequent entry into S phase [97].
Summary
The development of the nervous system is a tightly regulated process that includes
neurogenesis and removal of redundant neurons by apoptotic cell death. Zinc deficiency
affects neurogenesis in animal models, causes the arrest in the G1/S phase of the cell cycle
in human IMR-32 neuroblastoma cells, and induces apoptosis in animal and cell models.
These alterations can occur as a consequence of the deregulation of select signalling
cascades and cellular events that are summarized in Fig.1. Zinc deficiency-induced
deregulation of neuronal progenitor proliferation and increased neuronal apoptosis during
early development could irreversibly affect the nervous system and lead to impaired
behavior and locomotor performance, learning and memory deficits, and increased risk for
the development of neurological disorders later in life.
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Abbreviations
Akt serine-threonine kinase
Cdks cyclin-dependent kinases
DTPA diethylenetriamine pentaacetic acid
ERK extracellular-signal-regulated kinase
MAPK mitogen activated kinases
MOMP mitochondrial outer membrane permeabilization
NF-κB nuclear factor-kappa B
TPEN N,N,N′,N′-tetra-kis(2-pyridylmethyl)ethylenediamine
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Figure 1. Mechanisms involved in the impaired neurogenesis and triggering of apoptotic
neuronal death ehrn neuronal zinc decreases
A decreased zinc availability can affect cell proliferation and neuronal survival by affecting
multiple signaling pathways. Apoptosis can occur as a consequence of: a) a direct activation
of caspase-3, b) the inhibition of ERK1/2, and the consequent translocation of Bad to the
mitochondria and the occurrence of MOMP, c) p53-mediated increased expression of pro-
apoptotic genes, and d) a microtubule-mediated inhibition of the pro-survival signal NF-κB.
As a consequence of zinc deficiency, a decreased cell proliferation occurs due to an arrest of
the cell cycle in G0/G1 phase. The potential mechanisms involved include: a) an
upregulation of p53 that leads to an increased expression of p21, inhibitor of cdks, b)
ERK1/2 inhibition and a consequent decreased expression of cyclins D and E, c) alterations
in microtubule assembly that can affect the formation of the mitotic spindle, and d) NF-κB
inhibition.
Illustrated by the artist Andres Waissman (http://www.andreswaissman.com)
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